Stocks
BioAge Labs, Inc.BIOA
NASDAQHealthcareBiotechnology$18.72-5.86%
Developing therapeutics targeting aging and age-related diseases, BioAge Labs focuses on extending human healthspan through its pipeline of small-molecule and biologic candidates. The company has attracted investor attention for its approach to modulating key aging pathways, with partnerships including Amgen and a growing preclinical/clinical portfolio.
Market Cap: $671.2M52W Range: $2.88 – $24.00
Congressional Interest in BioAge Labs, Inc. (BIOA)
1 member of Congress has disclosed 1 trade in BioAge Labs, Inc. (BIOA), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading BIOA?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2016-06-09 | SUZAN K. DELBENE | sell | $1K – $15K |